MIAMI, FLORIDA / ACCESS Newswire / December 16, 2025 / AstraZeneca, Eastman, Kraft Heinz, and P&G have been recognized for ...

AbbVie and several other drugmakers are expected to announce on Friday agreements with the U.S. government to lower certain ...

Datopotamab Deruxtecan powder for concentrate for solution for infusion 100 mg (r-DNA origin) is indicated for the treatment ...

AstraZeneca Pharma India said the Central Drugs Standard Control Organisation (CDSCO) has granted permission to import, sell and distribute Datopotamab Deruxtecan powder in the country. Chalet Hotels ...

Israeli drug discovery and development company Compugen (Nasdaq: CGEN; TASE: CGEN) today announced changes in its ...

The White House is set to announce drug pricing deals with pharmaceutical heavyweights Novartis AG and Roche Holding AG as ...

Claim 50% Off TipRanks Premium and Invest with Confidence Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions Stay ahead of the market ...

Rilvegostomig is a first-in-class dual-checkpoint bispecific therapy that delivers coordinated PD-1 and TIGIT blockade on the same immune effector cell. AstraZeneca is currently advancing the drug in ...

Explore Pfizer Inc.’s 2025-2026 outlook: challenges, flat revenues, patent risks, and potential from the Metsera deal. Click ...

Ola Electric: Promoter Bhavish Aggarwal could sell additional shares in open market to bring down stake to 34-35% from 36.78% as of September ended quarter, sources told NDTV Profit. Post this, there ...

Earlier this year, Australia rolled out its newest screening program in 20 years, but can it reach those most at risk?

Regulators in the UK and US are the first to approve GSK's Exdensur, a long-acting, twice-yearly IL-5 inhibitor for severe ...